Bionet Cardio7e - Page 166

V 1.31
2021. 05 166 / 171 Doc. # : BN-OP-C7
Guidance and manufacturer’s declaration – electromagnetic immunity
The Cardio7e/Cardio7 is intended for use in the electromagnetic environment specified below.
The customer or the user of the should assure that it is used in such an environment.
IMMUNITY test
IEC 60601
test level
Compliance
level
Electromagnetic environment -
guidance
Conducted RF
IEC 61000-4-6
3 Vrms
150 kHz to 80MHz
3 V rms
Portable and mobile RF
communications equipment should be
used no closer to any part of the
Cardio7e/Cardio7, including cables,
than the recommended separation
distance calculated from the equation
applicable to the frequency of the
transmitter.
Recommended separation distance
Radiated RF
IEC 61000-4-3
3 V/m
80 MHz to 2,5 GHz
3 V/m
80 MHz to 800 MHz
800 MHz to 2,5 GHz
where P is the maximum output power
rating of the transmitter in watts (W)
according to the transmitter
manufacturer and d is the
recommended separation distance in
meters (m).
Field strengths from fixed RF
transmitters, as determined by an
electromagnetic site survey,
a
should be
less than the compliance level in each
frequency range.
b
Interference may occur in the vicinity of
equipment marked with the following
symbol:
NOTE 1 At 80 MHz and 800 MHz, the higher frequency range applies.
NOTE 2 These guidelines may not apply in all situations. Electromagnetic propagation is affected
by absorption and reflection from structures, objects and people.